Inlay butterfly cartilage tympanoplasty makes the graft easy, and reduces operating time. The present study aimed to investigate the outcomes of microscopic versus endoscopic inlay butterfly cartilage tympanoplasty. In this retrospective study, the outcomes of 63 patients who underwent inlay butterfly cartilage tympanoplasty with small to medium chronic tympanic membrane perforation were evaluated. Twenty-four patients underwent conventional microscopic tympanoplasty and 39 underwent endoscopic tympanoplasty. The outcomes were analyzed in terms of the hearing gain and graft success rate. The surgical success rate was 95.8% in the patients who underwent conventional microscopic tympanoplasty and 92.3% in those who underwent endoscopic tympanoplasty. In both groups of patients, the postoperative air-bone gap (ABG) was significantly lower than the preoperative ABG. There were no significant differences between the preoperative and postoperative ABG values in either group. Endoscopic inlay tympanoplasty using the butterfly cartilage technique appears to be an effective alternative to microscopic tympanoplasty and results in excellent hearing.
1 September 2018 in International Journal of Pediatric Otorhinolaryngology
Objectives. Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disorder characterized by recurrent epistaxis, telangiectasia, and visceral arteriovenous malformations (AVMs). Activin A receptor-like type 1 (ACVRL1/ALK1) and endoglin (ENG) are the principal genes whose mutations cause HHT. No multicenter study has yet investigated correlations between genetic variations and clinical outcomes in Korean HHT patients.Methods. Seventy-two members from 40 families suspected to have HHT based on symptoms were genetically screened for pathogenic variants of ACVRL1 and ENG. Patients with genetically diagnosed HHT were also evaluated.Results. In the HHT genetic screening, 42 patients from 24 of the 40 families had genetic variants that met the pathogenic criteria (pathogenic very strong, pathogenic strong, pathogenic moderate, or pathogenic supporting) based on the American College of Medical Genetics and Genomics Standards and Guidelines for either ENG or ACVRL1: 26 from 12 families (50%) for ENG, and 16 from 12 families (50%) for ACVRL1. Diagnostic screening of 42 genetically positive HHT patients based on the Curaçao criteria revealed that 24 patients (57%) were classified as having definite HHT, 17 (41%) as having probable HHT, and 1 (2%) as unlikely to have HHT. Epistaxis was the most common clinical presentation (38/42, 90%), followed by visceral AVMs (24/42, 57%) and telangiectasia (21/42, 50%). Five patients (12%) did not have a family history of HHT clinical symptoms.Conclusion. Only approximately half of patients with ACVRL1 or ENG genetic variants could be clinically diagnosed as having definite HHT, suggesting that genetic screening is important to confirm the diagnosis.
Objectives: This study investigated the clinical characteristics of patients with vestibular migraine (VM) with a specific focus on aural symptoms. Additionally, we explored the distinct features of patients with VM who were also diagnosed with Ménière’s disease (MDVM). Methods: In this retrospective cohort study conducted in a tertiary center from 2016 to 2020, we analyzed clinical features, audiovestibular test results, and symptom improvement following medical therapy in 169 patients with VM. Logistic regression was used to identify factors linked to symptom improvement. Data collected from patients with VM and MDVM were compared. Results: Patients with VM commonly experienced aural symptoms, with 47.9% experiencing ear fullness, 40.2% reporting tinnitus, and 17.2% experiencing hearing fluctuations. Logistic regression analysis revealed that aural symptoms were predictive of a lower probability of symptom improvement for headache (p = 0.005) and dizziness (p = 0.007). Eleven (6.5%) patients with VM with aural symptoms were diagnosed with MD and exhibited distinct hearing patterns. The patients with MDVM showed a greater drop at low frequencies (mean hearing threshold of 33.6 ± 6.7 dB vs. 20.6 ± 11.1 dB in MDVM and VM, respectively; p = 0.002) and aggravated hearing levels on final audiometry (30.8 ± 23.0 dB vs. 12.6 ± 7.1 dB, p = 0.027). Conclusions: Aural symptoms are common among patients with VM and are associated with a lower probability of migraine symptoms responding to medication. Patients with MDVM exhibit a distinct pattern of hearing loss, leading to deterioration, whereas other patients with VM and aural symptoms show preserved hearing levels.
21 July 2019 in Korean Journal of Otorhinolaryngology-Head and Neck Surgery